🇰🇷 MARGENZA in South Korea

MARGENZA (MARGETUXIMAB-CMKB) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

MARGENZA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in South Korea

Frequently asked questions

Is MARGENZA approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for MARGENZA in South Korea?

MACROGENICS INC is the originator. The local marketing authorisation holder may differ — check the official source linked above.